Mar 11, 2025 / 09:00AM GMT
Michael Willome - Synthomer PLC - Chief Executive Officer, Executive Director
Good morning, and welcome to our 2024 full year results presentation. I'm glad to see you here at the Royal Society of Chemistry in London, with many others joining online. As usual, I'm here with Lily Liu, our CFO, and Faisal Tabbah, Head of Investor Relations. And we look forward to answering your questions at the end.
Starting with our performance, against the backdrop of a period of suppressed demand in the chemical sector that lasts now since three years, we have delivered full year results with robust growth in revenue; EBITDA, EBIT, and improved underlying EPS all in line with expectations. Overall, volumes increased by significant 8.4%, despite generally slow end market demand. All three divisions showed growing volumes. We gained market share, particularly in AS division, and we are pleased to report today an increase in our revenue of 5%.
Our EBITDA increased by 9%, around GBP10 million, mostly reflecting our self-help, reliability, and cost actions, as well as our strategic reorientation with margins
Full Year 2024 Synthomer PLC Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
